Search details
1.
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
N Engl J Med
; 388(23): 2145-2158, 2023 06 08.
Article
in English
| MEDLINE | ID: mdl-36972026
2.
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
Br J Cancer
; 130(3): 425-433, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38097739
3.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
N Engl J Med
; 385(23): 2123-2131, 2021 12 02.
Article
in English
| MEDLINE | ID: mdl-34874631
4.
Implementing MyChoice® CDx HRD testing for the Nordics: lessons from 2021 to 2023.
Acta Oncol
; 63: 70-75, 2024 Mar 14.
Article
in English
| MEDLINE | ID: mdl-38482597
5.
Management of endometrial cancer in Latin America: raising the standard of care and optimizing outcomes.
Int J Gynecol Cancer
; 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38697755
6.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38627035
7.
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic.
Arch Gynecol Obstet
; 310(1): 577-586, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38836928
8.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-37060236
9.
Advances in the Management of Recurrent Cervical Cancer: State of the Art and Future Perspectives.
Curr Oncol Rep
; 25(11): 1307-1326, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37870697
10.
Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?
Int J Gynecol Cancer
; 33(11): 1675-1681, 2023 11 06.
Article
in English
| MEDLINE | ID: mdl-37640446
11.
Safety and management of niraparib monotherapy in ovarian cancer clinical trials.
Int J Gynecol Cancer
; 33(6): 971-981, 2023 06 05.
Article
in English
| MEDLINE | ID: mdl-36792166
12.
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
Int J Gynecol Cancer
; 33(12): 1943-1949, 2023 Dec 04.
Article
in English
| MEDLINE | ID: mdl-37907262
13.
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.
Int J Gynecol Cancer
; 33(11): 1733-1742, 2023 11 06.
Article
in English
| MEDLINE | ID: mdl-37931976
14.
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.
Int J Gynecol Cancer
; 33(7): 1023-1043, 2023 07 03.
Article
in English
| MEDLINE | ID: mdl-37369376
15.
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Lancet Oncol
; 23(8): e374-e384, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35901833
16.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 381(25): 2391-2402, 2019 12 19.
Article
in English
| MEDLINE | ID: mdl-31562799
17.
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.
Gynecol Oncol
; 167(2): 360-372, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36096973
18.
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
Gynecol Oncol
; 166(3): 494-502, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35851489
19.
Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context.
Future Oncol
; 18(23): 2505-2536, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35791804
20.
Patient perspectives and experiences of the rapid implementation of digital consultations during COVID-19 - a qualitative study among women with gynecological cancer.
Support Care Cancer
; 30(3): 2545-2554, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-34796401